Dare Bioscience (DARE) Common Equity (2016 - 2025)
Historic Common Equity for Dare Bioscience (DARE) over the last 11 years, with Q3 2025 value amounting to $2.9 million.
- Dare Bioscience's Common Equity rose 29251.84% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 29251.84%. This contributed to the annual value of -$6.0 million for FY2024, which is 1910.69% down from last year.
- Latest data reveals that Dare Bioscience reported Common Equity of $2.9 million as of Q3 2025, which was up 29251.84% from -$12.7 million recorded in Q2 2025.
- Dare Bioscience's 5-year Common Equity high stood at $38.8 million for Q4 2021, and its period low was -$12.7 million during Q2 2025.
- Moreover, its 5-year median value for Common Equity was $2.9 million (2025), whereas its average is $7.5 million.
- As far as peak fluctuations go, Dare Bioscience's Common Equity soared by 346487.02% in 2021, and later plummeted by 57663.23% in 2025.
- Quarter analysis of 5 years shows Dare Bioscience's Common Equity stood at $38.8 million in 2021, then crashed by 71.33% to $11.1 million in 2022, then tumbled by 145.42% to -$5.0 million in 2023, then fell by 19.11% to -$6.0 million in 2024, then skyrocketed by 147.54% to $2.9 million in 2025.
- Its Common Equity was $2.9 million in Q3 2025, compared to -$12.7 million in Q2 2025 and -$9.6 million in Q1 2025.